Antiretroviral (AIDS) Agents, Daily Dosage, and Major Toxicities - 2000
Page by: E.J. Mayeaux, Jr., M.D.
Louisiana State University Medical Center Shreveport, Louisiana
Nucleoside analogs
- Zidovudine, AZT (Retrovir)
- 500-600 mg po (typically 200 mg po tid) Children 3 mo- 1 2 yr:180 mg/M2 q6h, not to exceed 200 mg q6h
- Bone marrow suppression, Severe anemia, Granulocytopenia, Symptomatic myopathy, myositis (with prolonged use)
- Didanosine, ddl, (Videx)
- Two 100 mg tablets bid (> =60 kg), One 100 mg tab Plus one 25 mg tab bid (< 60 kg) Powder: 250 mg bid (> =60 kg)
- Pancreatitis, Peripheral neuropathy, Liver failure, Retinal depigmentation and change in vision (in children)
- Zalcitabine, ddc (Hivid)
- 0.75 mg po tid (0.375 mg po tid for patients <30 kg), 0.75 mg po tid
- Severe peripheral neuropathy, Pancreatitis, Esophageal ulcers, Cardiomyopathy/congestive heart failure, Anaphylactoid reaction
- Stavudine, d4T (Zerit)
- 40 mg po bid (>=60 kg), 30 mg po bid (<60 kg)
- Delayed peripheral neuropathy, Hepatotoxicity, Anemia (but decreased bone marrow toxicity in comparison to zidovudine)
- Lamivudine, 3TC (Epivir)
- 150 mg po bid (>50 kg) with AZT, 2 mg/kg po bid (<50 kg) with AZT
- Headache, insomnia, fatigue, peripheral neuropathy, myalgia
Protease inhibitors
- Saquinavir mesylate (Invirase)
- 600 mg po tid
- Generally well tolerated.
- Ritonavir (Norvir)
- 600 mg bid
- Generally well tolerated.
- Indinavir (Crixivan)
- 800 mg tid
- Generally well tolerated.
Return to The Intern in the Middle of the Night Home Page
Return to LSUHSC-S
Family Medicine Home Page
Return to the LSUHSC-S Home Page.